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A cDNA encoding a novel human eurotrophic factor (designated nerve growth factor-2; NGF-2) was cloned from a human glioma cDNA library 
using a synthetic DNA corresponding to human nerve growth factor (NGF). The cloned cDNA encodes a polypeptide composed of 257 amino 
acid residues including aprepro-sequence of 138 residues and a mature region of 119 residues. The amino acid sequence of human NGF-2 exhibits 
58% similarity with that of human NGF. Conditioned medium of COS-7 cells transfected with an expression plasmid for human NGF-2 cDNA 
supported the survival of sensory neurons isolated from dorsal root ganglia of embryonic chicks. A 1.5 kb of NGF-2 mRNA can be detected 
from an early development stage in rat brain, by Northern blotting analysis. 
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1. INTRODUCTION 
Neurotrophic factors are believed to play an essential 
role in the growth, survival, and differentiation of 
neurons in the nervous system. So far, several well- 
characterized neurotrophic factors have been reported. 
One is nerve growth factor (NGF) which was isolated 
from the male mouse submaxillary gland [1]. This fac- 
tor is essential for the survival and development of 
peripheral sensory and sympathetic neurons [2] and 
cholinergic neurons of the basal forebrain [3]. Another 
is brain-derived neurotrophic factor (BDNF) which is 
isolated from pig brain [4] and supports the survival of 
sensory neurons [5,6] but does not support the survival 
of sympathetic neurons [5]. The primary structure of 
BDNF deduced from the cDNA is structurally related 
to that of NGF [7]. 
To isolate other NGF related genes, we tried to screen 
a human glioma cDNA library under low stringent 
hybridization conditions using a synthetic DNA cor- 
responding to human NGF as a probe. The cDNA thus 
cloned encoded anovel neurotrophic factor (designated 
nerve growth factor-2, NGF-2). We report here the 
cloning and expression of human NGF-2 cDNA, and 
the presence of NGF-2 mRNA in several tissues in the 
rat. 
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2. MATERIALS AND METHODS 
2.1. cDNA cloning 
A 0.38 kb DNA fragment encoding human NGF was synthesized 
according to the nucleotide sequence reported by Ullrich et al. [8]. 
The DNA fragment was labelled by the oligolabelling reaction and us- 
ed as a probe. A Agtll human glioma (Hs683) cDNA library 
(Clontech Laboratories) was screened using nylon filters (Amersham) 
and the probe. Hybridization was carried out for 16 h at 60°C in 
6 x SSC (1 × SSC contains 150 mM NaCl and 15 mM sodium citrate), 
5xDenhardt's solution (i x Denhardt's olution contains 0.02% 
polyvinylpyrrolidone, 0.02% Ficoll and 0.02% bovine serum 
albumin), 0.1% SDS, and 20/zg/ml sonicated enatured salmon 
sperm DNA. The filters were washed three times each for 5 min at 
25°C in 2×SSC containing 0.1% SDS and then once for 90 min at 
60°C in I x SSC containing 0.1% SDS. The filters were autoradio- 
graphed onto Kodak X-AR films at -40°C with intensifying screens. 
Nucleotide sequence was determined by the dideoxy chain- 
termination method [9]. 
2.2. Northern blotting analysis 
Total RNAs were isolated from human glioma Hs683 cells and 
from the indicated tissues of the rat by the method of Chirgwin et al. 
[10]. Poly (A) ÷ RNAs were prepared by oligo(dT)-cellulose column 
chromatography (Pharmacia) [11]. Poly (A) ÷ RNAs were elec- 
trophoresed on 1.5% agarose gel containing formaldehyde and 
transferred toa nitrocellulose filter (S & S). DNA fragments contain- 
ing human NGF-2 cDNA, NGF gene cloned from a human genomic 
library, or rat NGF-2 gene cloned from a rat genomic library ex- 
hibiting 90% homology in nucleotide sequence with human NGF-2 
cDNA were labelled and used as probes. Hybridization was carried 
out as described above. The filters were washed 3times each for 5 min 
at 25 °C in 2 x SSC containing 0.1% SDS, and then once for 90 min 
at 68°C in 0.1xSSC containing 0.1% SDS. The filters were 
autoradiographed onto Kodak X-AR films at -40°C with intensify- 
ing screens. 
2.3. Biological assays 
COS-7 cells were transfected with each plasmid DNA using the 
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calcium phosphate coprecipitation technique [12] and grown for 24 h. 
After medium was replaced with Dulbecco's modified Eagle's 
medium (DMEM) containing 0.5°70 fetal calf serum (FCS), the cells 
were grown for 48 h. The biological activity for NGF-2 was assayed 
using dorsal root ganglia from embryonic day-8 chicks (ES) as 
described by Davies and Lindsay [13]. 
3. RESULTS 
3.1. Cloning and sequencing of  human NGF-2 cDNA 
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Fig. 1. (a) Schematic diagram of the cloned human NGF-2 cDNA showing the restriction endonuclease cleavage sites. The cDNA inserts of 
A~GN1321 and AHNT31 are aligned below the diagram with the coding sequence boxed. The stippled and dashed boxes indicate the putative signal 
and pro-sequences, respectively. The closed box shows the putative mature region. Restriction sites: N, Ncol; Sa, SacII; Sc, ScaI; A, AhaIII. (b) 
Nucleotide sequence and deduced amino acid sequence of the cloned human NGF-2 cDNA. The additional potential initiation codon is underscored 
with a double line. The putative signal sequence is underlined. The putative mature region is boxed. The Lys-Arg dipeptide which precedes the 
proteolytic cleavage site is underscored with a bold line. The one potential N-glycosylation site in the pro-region is indicated by a large dot. (c) 
Alignment of amino acid sequences of human prepro-NGF-2 and rat prepro-NGF-2. Asterisks indicate different amino acids. Hyphens are in- 
troduced for optimal alignment. 
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(Hs683) cDNA library under low stringent hybridiza- 
tion conditions using a 0.38 kb synthetic DNA fragment 
encoding human NGF as a probe. One positive clone, 
A~GN1321, was i olated from 5×105 plaques. The 
clone had an insert of 0.72 kb (Fig. la). Clones contain- 
ing additional 5' sequences were also isolated from the 
same library using the insert in A~'GN1321 as a probe. 
One of the clones, AHNT31, had an insert of 1.1 kb 
(Fig. la). 
The nucleotide sequence of the cDNA cloned in 
AHNT31 and the deduced amino acid sequence are 
shown in Fig. lb. The cDNA encodes a polypeptide of 
257 amino acids containing a region structurally related 
to human NGF. We named this polypeptide NGF-2. 
Comparison with the prepro-NGF suggests that the 
polypeptide contains a putative signal sequence of 18 
amino acid residues (residues - 138 through - 121) and 
a putative pro-sequence of 120 amino acid residues 
(residues -120 through -1 )  preceding the putative 
mature region (residues + 1 through + 119). The amino 
acid sequence of human NGF-2 (the putative mature 
region) exhibits 58% similarity with that of human 
NGF, and the positions of the 6 cysteine residues are 
conserved. 
Southern blotting analysis of human chromosomal 
DNA showed that NGF-2 gene exists as a single gene 
per haploid genome (data not shown). The NGF-2 
cDNA was also isolated from a human placental cDNA 
library, 
b 
3.2. Expression of human NGF-2 in mammalian cells 
The 1.1. kb EcoRI fragment of human NGF-2 cDNA 
prepared from AHNT31 was inserted downstream of 
the LTR region of Abelson murine leukemia virus and 
the SV40 promoter in the expression plasmid [14] to 
give pNTL145. The conditioned medium of COS-7 cells 
transfected with the plasmid pNTL145 supported the 
survival of sensory neurons of chicken E8 dorsal root 
ganglia (Fig. 2), and stimulated neurite outgrowth from 
rat pheochromocytoma PC12 cells (data not shown). In 
contrast, the conditioned medium of COS-7 cells 
transfected with the control plasmid pTB389 having no 
NGF-2 cDNA showed only a weak biological activity; 
this may be due to NGF endogenously produced by 
COS-7 cells (Fig. 2). 
3.3. Northern blotting analyses of NGF-2 mRNA 
Northern blotting analysis with human NGF-2 cDNA 
as a probe showed the presence of a 1.5 kb NGF-2 
mRNA in human glioma Hs683 cells (Fig. 3a; left lane). 
In addition, a 1.3 kb NGF mRNA was also detected in 
the cells using human NGF gene as a probe (Fig. 3a; 
right lane). 
Using rat NGF-2 gene as a probe, the synthesis of 
NGF-2 mRNA was examined in several tissues of the 
young adult rat (Fig. 3b). A large amount of NGF-2 
mRNA was detected in all the tissues examined except 
muscle and testis. The highest level of mRNA synthesis 
was observed in kidney. The developmental ime course 
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Fig. 2. The biological activity of conditioned medium of transfected COS-7 cells. Sensory neurons of chicken E8 dorsal root ganglia were grown 
for 5 days in the medium containing 5070 of the conditioned medium of COS-7 cells transfected with human NGF-2 expression plasmid pNTL 145 
(a) and with the control plasmid pTB389 (b); bar = 250/~m. Neurons were plated at 5000 cells per well and grown for 3 days, and the numbers 
of phase-bright neurons with neurites were counted (c). Dashed bars indicate the conditioned medium of COS-7 cells transfected with pNTL145, 
and blank bars indicate the conditioned medium of COS-7 cells transfected with pTB389. The values are the means of duplicate xperiments. 
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Fig. 3. (a) Analysis of NGF-2 mRNA in human glioma cells. Poly (A) + RNA (4.5/~g) was analyzed. Human NGF-2 cDNA (left lane) and human 
NGF gene (right lane) labelled were used as probes. Positions of ribosomal RNA markers are shown on the left. (b) Tissue distribution of NGF-2 
mRNA. Poly (A) + RNAs (about 6/~g) from the indicated tissues of the young adult rat were analyzed. Rat NGF-2 gene labelled was used as a 
probe. (c) Developmental expression pattern of NGF-2 mRNA in rat brain. Poly (A) + RNAs (about 10/zg) from rat brain were analyzed as above. 
E17.5 and E19.5 indicate mbryonic days 17.5 and 19.5, respectively; P1, 1W, 2W, and 3W indicate l day, 1 week, 2 weeks, and 3 weeks postnatal- 
ly, respectively. 
of NGF-2 gene expression in rat brain indicated that 
NGF-2 mRNA can be detected at embryonic day 17.5 
and that the level of NGF-2 mRNA synthesis reached a
maximum 1-2 weeks postnatally (Fig. 3c). In contrast, 
the level of actin mRNA synthesis was found almost 
equal in all above experiments (data not shown). 
4. DISCUSSION 
Cloning from a human glioma cDNA library using a 
synthetic human NGF gene as a probe under low 
stringent hybridization conditions resulted in the isola- 
tion of a cDNA structurally related to NGF. Transfec- 
tion experiments suggested that the cDNA encodes a
novel neurotrophic factor (NGF-2). Comparison with 
the primary structure of prepro-NGF suggests that 
NGF-2 has a prepro-sequence preceding the mature 
region. In fact, Western blotting using rabbit anti- 
human NGF-2 peptide antisera showed that COS-7 cells 
transfected with the expression plasmid pNTLI45 pro- 
duced in the medium an immunoreactive protein which 
migrated to the position corresponding to 15 kDa (data 
not shown). This suggests that proteolytic cleavage oc- 
curs between Arg(-1) and Tyr(+ 1) in Fig. lb. 
A comparison of the amino acid sequences of human 
NGF-2, human NGF, and pig BDNF showed that 
human NGF-2 exhibits 58°70 and 55070 similarity with 
human NGF and pig BDNF, respectively (Fig. 4). 
Recently Hohn et al. and Maisonpierre t al. reported 
the isolation of the genes for named neurotrophin-3 
(NT-3) from mouse and rat genomic DNA libraries, 
respectively [15,16]. The amino acid sequence of human 
NGF-2 was identical to those of the mouse and rat 
NT-3, although the sequences in the pro-sequence were 
significantly different between human NGF-2 and 
NT-3. This indicates that there are at least 3 NGF- 
related genes, NGF, NGF-2/NT-3, and BDNF. The 
high degree of structural conservation of NGF-2/NT-3 
° 
NoF2 Tyr olu . . . . .   Hls At,At" O1 OlY Olu,  r Ser Wl Cys  ,0ASP Ser, Trp  Thr . . . . .  
Phe HIs Glu Phe Ser Val Cys Ser Val Val Trp Val GL_ ~ . . . .  NGF Ser Ser ~ I le  Arg l  
BDNF HIs Asp Ala - - -  Arg Gly Glull~eu SO~ V~I ~y. Asp Ser J~ l le  Glu Trp Val Thr] Ala Ala 
NGF ThrlThrAla[Thr Val[-M'~Val Leu GI Glu Val Asn l le  Asn Val 
BDNF Lys Val Ser Gly ThrlVal Thr Val Leu l~.~j~Pro  Val Ser Lys Cly Gin 
Val Ly$ Gln Tyr Phe T r Glu Thr]Arg Lys Glu Ala Arg Pro Val L s Asn Gly C s Arg Gly l ie Asp Asp 
NGF Phe Lys Gln Tyr Phe Glu Thr Lys Cys Arg Asp Pro ASh Pro Val Set GIy Cys Arg Gly l ie  Asp Ser 
BDNF Leu Lys Gln Tyr Phe Tyr Glu Thr Lys Ash Pro Met Gly Tyr ThrlLyslGlu[Gly Cys Arg Gly I le  
NGF-2 Lys HIS Trp Ash Set Gln C~s Lys Set Gln Thr T r Val Ar Ala Leu Thr[Ser GIU ASh 
NGF L s HIS Trp Ash Ser[~3Cys Thr Thr Val Ala Leu Thr Met ASp Gly - - -  Gln Ala 
IJDNF HIS Trp Ash Ser Gln Cys Arg[Thr Thr GlnJSer~Tyr Val Arg Ala LeuThr Set Lys Arg l le 
NGF Ala Trp Arg I le  Arg l le Asp Thr['~'~Cys Val Cys Val LeuSer_~_~A!.~Lys Ala Arg Ala 
BDNF Trp Ar~ Phe I le  Ar~ I le  Asp Thr Set Cys Val C~s Thr|Leu]Thr Ile[Lys Arg[Gly Arg[ 
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among species indicates that NGF-2 /NT-3  could have a 
pr imordial  role in vivo. 
NGF is a neurotrophic factor essential for the sur- 
vival and development of sensory and sympathetic 
neurons and cholinergic neurons of the basal forebrain, 
and it is distributed in many peripheral tissues and in 
bra in [17,18]. In rat brain NGF mRNA begins to ac- 
cumulate after birth [19]. BDNF supports the survival 
of  sensory neurons and is distributed mainly in brain 
[7]. NGF-2 also seems to act on sensory neurons and 
sympathetic neurons. It is distributed in peripheral 
tissues as well as in brain and, in rat brain, NGF-2 
mRNA is synthesized from an early developmental 
stage. As these factors show specific tissue distr ibution 
and specific developmental expression, they may have 
distinct functions in vivo. The physiological role of 
NGF-2 is now under investigation. 
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